171
Views
49
CrossRef citations to date
0
Altmetric
Review

Management of recurrent Ewing sarcoma: challenges and approaches

&
Pages 2279-2288 | Published online: 27 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jessica Gartrell & Carlos Rodriguez-Galindo. (2021) Ewing sarcoma: investigational mono- and combination therapies in clinical trials. Expert Opinion on Investigational Drugs 30:6, pages 653-663.
Read now
Deepam Pushpam, Vikas Garg, Sandip Ganguly & Bivas Biswas. (2020) Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects. OncoTargets and Therapy 13, pages 5093-5112.
Read now

Articles from other publishers (47)

Ketki S Dantkale & Manjusha Agrawal. (2024) A Comprehensive Review of Current Trends in the Diagnosis and Treatment of Ovarian Germ Cell Tumors. Cureus.
Crossref
Kerri Jack. (2024) What Is Eating Your Bones?. Physician Assistant Clinics 9:1, pages 91-107.
Crossref
Jin-Ah Kim, Kenneth A. Crawford, Piero A. Spada, Leah R. Martin, Jiaqi Zhang, Rain Wong, Joel M. Reid, Clinton F. Stewart, Timothy M. Frank, Qianqian Liu, Joel E. Michalek & Charles Keller. (2023) Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma. Scientific Reports 13:1.
Crossref
Sergey Tsibulnikov, Daria Fayzullina, Irina Karlina, Brett A. Schroeder, Olga Karpova, Peter Timashev & Ilya Ulasov. (2023) Ewing sarcoma treatment: a gene therapy approach. Cancer Gene Therapy 30:8, pages 1066-1071.
Crossref
Agung Kenji Arnaya, I Ketut Suyasa, I Gede Eka Wiratnaya & I Wayan Juli Sumadi. (2023) Differences in Cell Death and BMP-2 Expression in Core Biopsy Specimens of Malignant Bone Tumors Given Hydrogen Peroxide Compared to Liquid Nitrogen. European Journal of Medical and Health Sciences 5:4, pages 6-10.
Crossref
Elizabeth Gonzalez, Atif A. Ahmed, Laura McCarthy, Katherine Chastain, Sahibu Habeebu, Marta Zapata-Tarres, Rocio Cardenas-Cardos, Liliana Velasco-Hidalgo, Celso Corcuera-Delgado, Rodolfo Rodriguez-Jurado, Lilia García-Rodríguez, Alejandro Parrales, Tomoo Iwakuma, Midhat S. Farooqi, Brian Lee, Scott J. Weir & Terrie G. Flatt. (2023) Perinucleolar Compartment (PNC) Prevalence as an Independent Prognostic Factor in Pediatric Ewing Sarcoma: A Multi-Institutional Study. Cancers 15:8, pages 2230.
Crossref
Xiangwen Shi, Yipeng Wu, Linmeng Tang, Haonan Ni & Yongqing Xu. (2023) Downregulated annexin A1 expression correlates with poor prognosis, metastasis, and immunosuppressive microenvironment in Ewing’s sarcoma. Aging 15:6, pages 2321-2346.
Crossref
Carlos Julio Vargas-Potes, Diana Marcela Mendoza-Urbano, Luis Gabriel Parra-Lara & Ángela R. Zambrano. (2023) Desafíos en el manejo del sarcoma de Ewing en una paciente testigo de Jehová. Biomédica 43:1, pages 44-50.
Crossref
Yair Peled, Dror Levin, Shelly Shiran, Michal Manisterski & Ronit Elhasid. (2022) Cabozantinib as a successful salvage therapy in chemo‐refractory Ewing sarcoma. Pediatric Blood & Cancer 70:3.
Crossref
Staci L. Haney, Dan Feng, Yashpal S. Chhonker, Michelle L. Varney, Jacob T. Williams, Lynette M. Smith, James B. Ford, Daryl J. Murry & Sarah A. Holstein. (2022) Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma. Drug Development Research 84:1, pages 62-74.
Crossref
Upendra Kumar Soni, Yuhua Wang, Ram Naresh Pandey, Ryan Roberts, Joseph G. Pressey & Rashmi S. Hegde. (2023) Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition. Clinical Cancer Research 29:2, pages 458-471.
Crossref
Nail Paksoy, Ferhat Ferhatoglu, İzzet Dogan, Nijat Khanmammadov, Ayca Iribas Celik, Zafer GulbasMert Başaran. (2022) High-dose chemotherapy followed by autologous stem cell transplantation for adult patients With first relapse of Ewing’s sarcoma: A single institution experience. Medicine 101:49, pages e32213.
Crossref
Zhirui Ning. (2022) Combined Effects of PC002 and Anticancer Drugs in Ewing's Sarcoma Cells. Combined Effects of PC002 and Anticancer Drugs in Ewing's Sarcoma Cells.
Shunsuke Yahiro, Teruya Kawamoto, Shuichi Fujiwara, Hitomi Hara, Naomasa Fukase, Ryoko Sawada, Toshiyuki Takemori, Tomohiro Miyamoto, Yutaka Mifune, Kenichiro Kakutani, Yuichi Hoshino, Shinya Hayashi, Tomoyuki Matsumoto, Takehiko Matsushita, Michiyo Koyanagi‑aoi, Takashi Aoi, Ryosuke Kuroda & Toshihiro Akisue. (2022) Identification and characterization of slow‑cycling cells in Ewing sarcoma. International Journal of Oncology 61:5.
Crossref
Wenle Li, Shengtao Dong, Yuewei Lin, Huitao Wu, Mengfei Chen, Chuan Qin, Kelin Li, JunYan Zhang, Zhi-Ri Tang, Haosheng Wang, Kang Huo, Xiangtao Xie, Zhaohui Hu, Sirui Kuang & Chengliang Yin. (2022) A tool for predicting overall survival in patients with Ewing sarcoma: a multicenter retrospective study. BMC Cancer 22:1.
Crossref
Ayşe Özkan, İbrahim Bayram, Gülay Sezgin, Akif Mirioğlu & Serhan Küpeli. (2022) Efficacy of replacing actinomycin-D with carboplatin in Ewing sarcoma consolidation treatment: Single-center experience. Journal of Bone Oncology 35, pages 100435.
Crossref
Martin S. Highley, Bart Landuyt, Hans Prenen, Peter G. Harper & Ernst A. De Bruijn. (2022) The Nitrogen Mustards. Pharmacological Reviews 74:3, pages 552-599.
Crossref
Chelsea Self, Kyle L. MacQuarrie & Carrye R. Cost. (2022) Osteosarcoma/Ewing Sarcoma. Pediatrics In Review 43:5, pages 256-265.
Crossref
Chiyun Wang, Brendan C. Dickson, Adam C. Smith, Andrew J. Hope & Hyang Mi Ko. (2021) Endobronchial ultrasound‐guided fine needle aspiration diagnosis of metastatic FUS‐ERG ‐rearranged extraskeletal Ewing sarcoma following 15 years of untreated metastatic recurrence . Cytopathology 33:3, pages 389-392.
Crossref
Binbin Chen, Huimou Chen, Suying Lu, Xiaoqin Zhu, Yi Que, Yu Zhang, Junting Huang, Li Zhang, Yu Zhang, Feifei Sun, Juan Wang, Jia Zhu, Zijun Zhen & Yizhuo Zhang. (2022) KDM5B promotes tumorigenesis of Ewing sarcoma via FBXW7/CCNE1 axis. Cell Death & Disease 13:4.
Crossref
Daria Fayzullina, Sergey Tsibulnikov, Mikhail Stempen, Brett A. Schroeder, Naveen Kumar, Rajesh Kumar Kharwar, Arbind Acharya, Peter Timashev & Ilya Ulasov. (2022) Novel Targeted Therapeutic Strategies for Ewing Sarcoma. Cancers 14:8, pages 1988.
Crossref
Hong De Sa, John Pearl, Anna Maria Hibbs, Maria Pereda, Izumi Suzuki, Sean Curtis & Duncan Stearns. (2022) Congenital Ewing Sarcoma Presenting as a Rapidly Growing Neck Mass in a Newborn. Advances in Neonatal Care 22:1, pages 42-46.
Crossref
Robert M. Tungate, Kristi Lara, Dakshesh Patel, Alexander Fedenko & James Hu. (2022) Remission of a Primary, Recurrent Thoracic Ewing Sarcoma in a 74-year-old woman. Rare Tumors 14, pages 203636132211108.
Crossref
Giulia Golinelli, Giulia Grisendi, Massimiliano Dall'Ora, Giulia Casari, Carlotta Spano, Rebecca Talami, Federico Banchelli, Malvina Prapa, Chiara Chiavelli, Filippo Rossignoli, Olivia Candini, Roberto D'Amico, Milena Nasi, Andrea Cossarizza, Livio Casarini & Massimo Dominici. (2022) Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma. Translational Oncology 15:1, pages 101240.
Crossref
Osama Zakzok, Mohamed Elshanshory, Wael Zekri, Nahla Elsharkawy, Iman Zaky, Asmaa Salama, Ahmed Kamel, Ismail Elantably & Shebl Said. (2021) Prognostic value of detection of CD99 + , CD45 − cells in peripheral blood by flow cytometry in children with Ewing sarcoma . Pediatric Blood & Cancer 69:1.
Crossref
Amal M. Shoeib, Azure L. Yarbrough, Benjamin M. Ford, Lirit N. Franks, Alicja Urbaniak, Lori L. Hensley, Lance N. Benson, Shengyu Mu, Anna Radominska-Pandya & Paul L. Prather. (2021) Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development. Life Sciences 285, pages 119993.
Crossref
Caroline Guigou, Marie-Hélène Aubriot Lorton, Maxime Lleu & Alexis Bozorg Grayeli. (2021) Cerebellopontine Angle Ewing-like BCOR-rearranged Sarcoma Mimicking Vestibular Schwannoma. Otology & Neurotology 42:7, pages 1086-1088.
Crossref
Andy Dong, Mung Yan Lin, Matthew T. Brown & Ananth Vadde. (2021) Paraneoplastic Neurologic Syndrome in Ewing Sarcoma. The American Journal of Medicine 134:8, pages e457-e458.
Crossref
Marissa A. Just, David Van Mater & Lars M. Wagner. (2021) Receptor tyrosine kinase inhibitors for the treatment of osteosarcoma and Ewing sarcoma. Pediatric Blood & Cancer 68:8.
Crossref
Sebastian Dorin Asaftei, Nadia Puma, Anna Paioli, Marco Petraz, Carlo Morosi, Marta Podda, Angela Tamburini, Emanuela Palmerini, Luca Coccoli, Giovanni Grignani, Carla Manzitti, Rossella Bertulli, Francesco De Leonardis, Marco Rabusin, Anna Campello, Elisa Tirtei, Piero Picci, Arcangelo Prete, Alessandra Longhi, Franca Fagioli & Roberto Luksch. (2021) Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study. Cancers 13:12, pages 3046.
Crossref
Adil Abbas & Mohammed N.S. Alaa. (2021) Ewing Sarcoma Family Tumors: Past, Present and Future Prospects. Current Cancer Therapy Reviews 17:2, pages 107-136.
Crossref
Chiara Agnoletto, Chiara Caruso & Cecilia Garofalo. (2021) Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice. Cancers 13:9, pages 2189.
Crossref
Lizhen Qu, Wu Zhang, Jiajiang Li & Peng Liu. (2021) The miR-146b-5p promotes Ewing’s sarcoma cells progression via suppressing the expression of BTG2. Science Progress 104:2, pages 003685042110020.
Crossref
Kalasekhar VijayasekharanSubramaniam RamanathanGirish ChinnaswamyMaya PrasadAshish GuliaAmit JanuBharat RekhiMukta RamadwarNehal KhannaSiddhartha LaskarNilendu PuranadareJyoti BajpaiAjay PuriShripad BanavaliTushar Vora. (2021) High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen. Journal of Adolescent and Young Adult Oncology 10:2, pages 185-192.
Crossref
Giovanni Cochetti, Alessio Paladini, Jacopo Adolfo Rossi de Vermandois, Sonia Fatigoni, Magda Zanelli, Stefano Ascani & Ettore Mearini. (2021) Metastatic renal Ewing’s sarcoma in adult woman: Case report and review of the literature. Open Medicine 16:1, pages 397-409.
Crossref
Giacomo Domenici, Rodrigo Eduardo, Helena Castillo-Ecija, Gorka Orive, Ángel Montero Carcaboso & Catarina Brito. (2021) PDX-Derived Ewing’s Sarcoma Cells Retain High Viability and Disease Phenotype in Alginate Encapsulated Spheroid Cultures. Cancers 13:4, pages 879.
Crossref
Carolina Bernauer, Y. K. Stella Man, Julia C. Chisholm, Elise Y. Lepicard, Simon P. Robinson & Janet M. Shipley. (2020) Hypoxia and its therapeutic possibilities in paediatric cancers. British Journal of Cancer 124:3, pages 539-551.
Crossref
Esra Guzel Tanoglu, Yavuz Arıkan, Yavuz Selim Kabukcuoglu, Fevziye Kabukcuoglu, Alpaslan Tanoglu & Sukru Ozturk. (2021) Mir-129-2-3p Has Tumor Suppressor Role in Ewing Sarcoma Cell Lines and Cancer Tissue Samples. Brazilian Archives of Biology and Technology 64.
Crossref
Jessica L. Davis & Erin R. Rudzinski. (2020) Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know?. Current Treatment Options in Oncology 21:11.
Crossref
Paulina Jagodzińska-Mucha, Iwona Ługowska, Tomasz Świtaj, Hanna Koseła-Paterczyk, Michał Wągrodzki, Katarzyna Kozak, Sławomir Falkowski, Tadeusz Morysiński, Tomasz Goryń, Anna Dawidowska & Piotr Rutkowski. (2020) The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcoma. International Journal of Clinical Oncology 25:11, pages 2006-2014.
Crossref
Javier E. Oesterheld, Damon R. Reed, Bhuvana A. Setty, Michael S. Isakoff, Patrick Thompson, Hong Yin, Masanori Hayashi, David M. Loeb, Tiffany Smith, Rikesh Makanji, Brooke L. Fridley & Lars M. Wagner. (2020) Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatric Blood & Cancer 67:7.
Crossref
Katie Parisio, David Spencer Mangum & Jonathan Powell. (2020) A novel and successful therapeutic approach in the treatment of a patient with simultaneous relapsed Ewing sarcoma and therapy‐related acute myeloid leukemia. Pediatric Blood & Cancer 67:7.
Crossref
Mouadh Barbirou, Ikram Sghaier, Sinda Bedoui, Rahma Ben Abderrazek, Hazar Kraiem, Azer Farah, Rym Hassiki, Amina Mokrani, Amel Mezlini, Wassim Y Almawi, Besma Loueslati-Yacoubi & Balkiss Bouhaouala-Zahar. (2020) KCNB1 gene polymorphisms and related indel as predictor biomarkers of treatment response for colorectal cancer – toward a personalized medicine . Tumor Biology 42:6, pages 101042832092523.
Crossref
Zhichao Zhou, Yuanzheng Yang, Fei Wang & Eugenie S. Kleinerman. (2020) Neuronal Repressor REST Controls Ewing Sarcoma Growth and Metastasis by Affecting Vascular Pericyte Coverage and Vessel Perfusion. Cancers 12:6, pages 1405.
Crossref
Antoine Italiano, Olivier Mir, Simone Mathoulin-Pelissier, Nicolas Penel, Sophie Piperno-Neumann, Emmanuelle Bompas, Christine Chevreau, Florence Duffaud, Natacha Entz-Werlé, Esma Saada, Isabelle Ray-Coquard, Cyril Lervat, Nathalie Gaspar, Perrine Marec-Berard, Hélène Pacquement, John Wright, Maud Toulmonde, Alban Bessede, Amandine Crombe, Michèle Kind, Carine Bellera & Jean-Yves Blay. (2020) Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial. The Lancet Oncology 21:3, pages 446-455.
Crossref
Yajun Deng, Qiqi Xie, Guangzhi Zhang, Shaoping Li, Zuolong Wu, Zhanjun Ma, Xuegang He, Yicheng Gao, Yonggang Wang, Xuewen Kang & Jing Wang. (2019) Slow skeletal muscle troponin T, titin and myosin light chain 3 are candidate prognostic biomarkers for Ewing's sarcoma. Oncology Letters.
Crossref
Christian Bailly. (2019) Irinotecan: 25 years of cancer treatment. Pharmacological Research 148, pages 104398.
Crossref